Skip to main content
Journal cover image

Improve time to anti-coagulation reversal for hemorrhagic strokes.

Publication ,  Journal Article
Dymm, B; Graffagnino, C; Acosta, GT; Ehrlich, ME; Monk, L; Shah, S; Iversen, E; Kolls, BJ; IMPROVE stroke consortium
Published in: J Stroke Cerebrovasc Dis
December 2024

BACKGROUND: Oral anticoagulation (OAC) is a risk factor for intracerebral hemorrhage (ICH) which is an important source of disability and mortality. OAC-associated ICH (OAC-ICH) patients have worse outcomes as compared to ICH patients not on OAC, likely because of the associated larger stroke volumes, higher propensity to intraventricular hemorrhage, and a higher risk of rebleeding. Although current guidelines recommend that OAC should be reversed quickly, many health care systems have not developed a process for optimizing that aspect of care. METHODS: Through the IMPROVE Stroke Care Consortium, a group of nine Hub hospitals and their 57 regional community hospitals, a systems of care improvement project was implemented. Performance reviews identified best practices which were disseminated throughout all centers. We compared the median door-to-reversal (DTR) time before and after an institutional campaign to speed the process with a target time of 60 min. RESULTS: Over two years of the study, there were 6,699 ischemic strokes, 152 subarachnoid hemorrhages, and 889 intracerebral hemorrhages. During that time, 73 ICH patients received reversal agents emergently. The overall baseline median DTR time was 123 min (IQR 99, 361 minutes). By the end of the program, the median DTR time had trended down to 84 min (IQR 58.5, 151 min) which is a 31.7 % reduction of DTR from baseline, though times remained somewhat variable (p=0.08). CONCLUSIONS: An integrated stroke systems of care approach was associated with a reduction in DTR times for patients presenting with acute ICH and concurrent use of anticoagulants despite lack of definitive guidelines around targets for OAC reversal times or operational guidance on protocols and agents.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Stroke Cerebrovasc Dis

DOI

EISSN

1532-8511

Publication Date

December 2024

Volume

33

Issue

12

Start / End Page

108090

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Time-to-Treatment
  • Time Factors
  • Risk Factors
  • Quality Indicators, Health Care
  • Quality Improvement
  • Program Evaluation
  • Neurology & Neurosurgery
  • Middle Aged
  • Male
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Dymm, B., Graffagnino, C., Acosta, G. T., Ehrlich, M. E., Monk, L., Shah, S., … IMPROVE stroke consortium. (2024). Improve time to anti-coagulation reversal for hemorrhagic strokes. J Stroke Cerebrovasc Dis, 33(12), 108090. https://doi.org/10.1016/j.jstrokecerebrovasdis.2024.108090
Dymm, Braydon, Carmelo Graffagnino, Gabriel Torrealba Acosta, Matthew E. Ehrlich, Lisa Monk, Shreyansh Shah, Edwin Iversen, Brad J. Kolls, and IMPROVE stroke consortium. “Improve time to anti-coagulation reversal for hemorrhagic strokes.J Stroke Cerebrovasc Dis 33, no. 12 (December 2024): 108090. https://doi.org/10.1016/j.jstrokecerebrovasdis.2024.108090.
Dymm B, Graffagnino C, Acosta GT, Ehrlich ME, Monk L, Shah S, et al. Improve time to anti-coagulation reversal for hemorrhagic strokes. J Stroke Cerebrovasc Dis. 2024 Dec;33(12):108090.
Dymm, Braydon, et al. “Improve time to anti-coagulation reversal for hemorrhagic strokes.J Stroke Cerebrovasc Dis, vol. 33, no. 12, Dec. 2024, p. 108090. Pubmed, doi:10.1016/j.jstrokecerebrovasdis.2024.108090.
Dymm B, Graffagnino C, Acosta GT, Ehrlich ME, Monk L, Shah S, Iversen E, Kolls BJ, IMPROVE stroke consortium. Improve time to anti-coagulation reversal for hemorrhagic strokes. J Stroke Cerebrovasc Dis. 2024 Dec;33(12):108090.
Journal cover image

Published In

J Stroke Cerebrovasc Dis

DOI

EISSN

1532-8511

Publication Date

December 2024

Volume

33

Issue

12

Start / End Page

108090

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Time-to-Treatment
  • Time Factors
  • Risk Factors
  • Quality Indicators, Health Care
  • Quality Improvement
  • Program Evaluation
  • Neurology & Neurosurgery
  • Middle Aged
  • Male